Abstract
Gastrointestinal manifestations resulting from either prescribed medications or over-the-counter drugs are commonly encountered in clinical practice and often mistaken for a disease process or syndrome, leading to multiple and unnecessary diagnostic studies. The morbidity, mortality, and health care costs associated with adverse drug events, even restricted to the GI tract, are underestimated. The consequences of adverse effects may be asymptomatic or range from mild discomfort to fatal hemorrhage or perforation. Better awareness and recognition of the intended and unacceptable effects of drugs on the gastrointestinal tract and withdrawing the medication or revising the regimen will help improve outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
FDA. Annual adverse drug report 1995. 1995. http://www.fda.gov/cder/reports/annrep95.pdf.
Jorgensen T, Johansson S, Kennerfalk A, et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001;35(9):1004–9.
Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795–801.
Nolan L, O’Malley K. Prescribing for the elderly. Part I: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc. 1988;36(2):142–9.
Jain V, Pitchumoni CS. Gastrointestinal side effects of prescription medications in the older adult. J Clin Gastroenterol. 2009;43(2):103–10.
Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096–9.
Abdollahi M, Radfar M. A review of drug-induced oral reactions. J Contemp Dent Pract. 2003;4(1):10–31.
Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med. 1995;333(24):1600–7.
Unnikrishnan D, Murakonda P, Dharmarajan TS. If it is not cough, it must be dysgeusia: differing adverse effects of angiotensin-converting enzyme inhibitors in the same individual. J Am Med Dir Assoc. 2004;5(2):107–10.
Taybos G. Oral changes associated with tobacco use. Am J Med Sci. 2003;326(4):179–82.
Carlborg B, Densert O. Esophageal lesions caused by orally administered drugs. An experimental study in the cat. Eur Surg Res. 1980;12(4):270–82.
Abid S, Mumtaz K, Jafri W, et al. Pill-induced esophageal injury: endoscopic features and clinical outcomes. Endoscopy. 2005;37(8):740–4.
O’Neill JL, Remington TL. Drug-induced esophageal injuries and dysphagia. Ann Pharmacother. 2003;37(11):1675–84.
Castell DO, Murray JA, Tutuian R, et al. The pathophysiology of gastro-oesophageal reflux disease—oesophageal manifestations. Aliment Pharmacol Ther. 2004;20 Suppl 9:14–25.
Shaker R. Gastroesophageal reflux disease: beyond mucosal injury. J Clin Gastroenterol. 2007;41 Suppl 2:S160–2.
Lichtenstein DR, Syngal S, Wolfe MM. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheum. 1995;38(1):5–18.
Schoen RT, Vender RJ. Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med. 1989;86(4):449–58.
Dominick KL, Ahern FM, Gold CH, Heller DA. Gender differences in NSAID use among older adults with osteoarthritis. Ann Pharmacother. 2003;37(11):1566–71.
Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med. 1998;158(1):33–9.
Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114(4):257–63.
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.
Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992;327(11):749–54.
Gibson GR, Whitacre EB, Ricotti CA. Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. Arch Intern Med. 1992;152(3):625–32.
Li F, Gurudu SR, De Petris G, Sharma VK, et al. Retention of the capsule endoscope: a single-center experience of 1000 capsule endoscopy procedures. Gastrointest Endosc. 2008;68(1):174–80.
Vandraas KF, Spigset O, Mahic M, Slordal L. Non-steroidal anti-inflammatory drugs: use and co-treatment with potentially interacting medications in the elderly. Eur J Clin Pharmacol. 2010;66(8):823–9.
Rahme E, Barkun A, Nedjar H, et al. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol. 2008;103(4):872–82.
Pusztaszeri MP, Genta RM, Cryer BL. Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations. Nat Clin Pract Gastroenterol Hepatol. 2007;4(8):442–53.
Ingoldby CJ. Perforated jejunal diverticulum due to local iron toxicity. BMJ. 1977;1(6066):949–50.
Saltzman JR, Kowdley KV, Pedrosa MC, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology. 1994;106(3):615–23.
Dharmarajan TS, Kanagala MR, Murakonda P, et al. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008;9(3):162–7.
Stamm C, Burkhalter CE, Pearce W, et al. Benign colonic ulcers associated with nonsteroidal antiinflammatory drug ingestion. Am J Gastroenterol. 1994;89(12):2230–3.
Halter F, Weber B, Huber T, et al. Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J Clin Gastroenterol. 1993;16(1):74–80.
Brandt LJ, Boley SJ. Colonic ischemia. Surg Clin North Am. 1992;72(1):203–29.
Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004;99(6):1175–90.
Dial S, Delaney JA, Schneider V, Suissa S. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ. 2006;175(7):745–8.
Al-Tureihi FI, Hassoun A, Wolf-Klein G, Isenberg H. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficile-associated disease in nursing home patients. J Am Med Dir Assoc. 2005;6(2):105–8.
Linsky A, Gupta K, Lawler EV, et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010;170(9):772–8.
Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol. 2005;26(3):273–80.
Petruzzelli GJ, Johnson JT, de Vries EJ. Neutropenic enterocolitis. A new complication of head and neck cancer chemotherapy. Arch Otolaryngol Head Neck Surg. 1990;116(2):209–11.
Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol. 2007;5(10):1126–39; quiz 1121–2.
Dharmarajan TS, Kumar A, Pitchumoni CS. Drug-nutrient interactions in older adults. Pract Gastroenterol. 2002;26(9):37–55.
Gizzi G, Villani V, Brandi G, et al. Ano-rectal lesions in patients taking suppositories containing non-steroidal anti-inflammatory drugs (NSAIDs). Endoscopy. 1990;22(3):146–8.
de Parades V, Sultan S, Bauer P. Ano-rectal and colonic complications of suppositories and enemas. Gastroenterol Clin Biol. 1996;20(5):446–52.
Lankisch PG, Droge M, Gottesleben F. Drug induced acute pancreatitis: incidence and severity. Gut. 1995;37(4):565–7.
Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648–61; quiz 4.
Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005;39(8):709–16.
Pariente A, Sanctussy DJ, Miremont-Salame G, et al. Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting. CNS Drugs. 2010;24(1):55–63.
Becker WC, O’Connor PG. The safety of opioid analgesics in the elderly: new data raise new concerns: comment on “the comparative safety of opioids for nonmalignant pain in older adults”. Arch Intern Med. 2010;170(22):1986–8.
Cho S, Lau SWJ, Tandon V, et al. Geriatric drug evaluation. Where are we now and where should we be in the future? Arch Intern Med. 2011;171(10):937–40.
Hiraishi H, Maeda M, Sasai T, et al. Strategy to manage low dose aspirian-induced gastrointestinal injury. Nippon Rinsho. 2011;69(2):369–75.
Laria A, Zoli A, Gremese E, Ferraccioli GF. Proton pump inhibitors in rheumatic diseases; clinical practice, drug interactions, bone fractures and risk of infections. Reumatismo. 2011;63(1):5–10.
Schulman S, Majeed A. A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery. Drug Saf. 2011;3496:449–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jain, V. et al. (2012). Drug Effects on the Gastrointestinal Tract. In: Pitchumoni, C., Dharmarajan, T. (eds) Geriatric Gastroenterology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1623-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1623-5_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1622-8
Online ISBN: 978-1-4419-1623-5
eBook Packages: MedicineMedicine (R0)